Description
ADM (22-52) is a putative adrenomedullin receptor antagonist that inhibits the production of cAMP elicted by adrenomedullin. It is a more effective antagonist for adrenomedullin- and CGRP-specific receptors than α-CGRP (8-37) (human).
Adrenomedullin (22-52) (human)
Price range: $261.61 through $469.52
ADM (22-52) is a putative adrenomedullin receptor antagonist that inhibits the production of cAMP elicted by adrenomedullin. It is a more effective antagonist for adrenomedullin- and CGRP-specific receptors than α-CGRP (8-37) (human).
Related products
-
((R)-4-Hydroxy-4-methyl-Orn(5-TAMRA)⁷)-Phalloidin
$931.00 -
((R)-4-Hydroxy-4-methyl-Orn(CPM-β-Mpa)⁷)-Phalloidin
$202.20 -
(2-(1,3-Dithiolan-2-yl)-Trp²⁵)-Liraglutide trifluoroacetate salt
Price range: $443.00 through $2,635.40 -
(2-(2-Trifluoromethyl-1,3-dithiolan-2-yl)-Trp²⁵)-Liraglutide trifluoroacetate salt
Price range: $495.73 through $2,949.45 -
(2-Hydroxy-Trp²⁵)-Liraglutide trifluoroacetate salt
Price range: $443.00 through $2,635.40